Patent · US Active

Chimeric adenoviral vectors

US8999946B2 · kind B2 · utility

0Cited by
4References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 25, 2012
Grant dateApr 7, 2015
Priority date
Expiry dateNov 27, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.